Highlights from the 6th SScWC 2020 E-Congress – slide kit

Nuove analisi dello studio clinico SENSCIS su SSc-ILD presentate al 6° SSc WC Congress, 2020

banner-articoli

 

Nel seguente slide kit sono riportate le principali analisi in ambito SSc-ILD presentate al Congresso Internazionale SScWC, 2020:

  • Disease course of progressive interstitial lung disease in systemic sclerosis: a 5-year follow-up from the EUSTAR database (Hoffmann-Vold AM)

  • Does doseadjustment affect decline in forced vital capacity in patients treated with nintedanib? (Mayes MD)

  • Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) (Khanna D)

  • Effect of nintedanib in patients with extensive and limited systemic sclerosis-associated ILD (Denton CP)

  • Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) over 100 weeks (Assassi S)

ARTICOLI CORRELATI

LEGGI
Card image
APPROFONDIMENTI

Highlights from the 6th SScWC 2020 E-Congress – slide kit

Nuove analisi dello studio clinico SENSCIS su SSc-ILD presentate al 6° SSc WC Congress, 2020
LEGGI
Card image
APPROFONDIMENTI

SENSCIS trial: additional analysis presented at Virtual EULAR 2020

Nuove analisi dello studio SENSCIS (Nintedanib in SSc-ILD) presentate a European League Against Rheumatism (EULAR) 2020 Virtual Congress – Slide kit
LEGGI
Card image
APPROFONDIMENTI

Highlights from the ATS International Congress

Report sulle ultime novità in ambito ILD emerse dal Congresso Internazionale ATS, Agosto 2020